310 related articles for article (PubMed ID: 26517361)
1. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.
Mascart F; Locht C
Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
Delogu G; Provvedi R; Sali M; Manganelli R
Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
[TBL] [Abstract][Full Text] [Related]
3. The tuberculosis vaccine challenge.
Brennan MJ
Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
[TBL] [Abstract][Full Text] [Related]
4. Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.
Méndez-Samperio P
Scand J Immunol; 2016 Oct; 84(4):204-10. PubMed ID: 27454335
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
6. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
Choi HG; Choi S; Back YW; Paik S; Park HS; Kim WS; Kim H; Cha SB; Choi CH; Shin SJ; Kim HJ
Oncotarget; 2017 Mar; 8(12):19947-19967. PubMed ID: 28193909
[TBL] [Abstract][Full Text] [Related]
7. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
9. Mouse and guinea pig models for testing new tuberculosis vaccines.
Orme IM
Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022
[TBL] [Abstract][Full Text] [Related]
10. Novel tuberculosis vaccines on the horizon.
Parida SK; Kaufmann SH
Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
[TBL] [Abstract][Full Text] [Related]
11. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
12. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in tuberculosis vaccines.
Haile M; Källenius G
Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
[TBL] [Abstract][Full Text] [Related]
14. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
Derrick SC; Yabe IM; Yang A; Morris SL
Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
[TBL] [Abstract][Full Text] [Related]
16. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
[TBL] [Abstract][Full Text] [Related]
17. Development of a new tuberculosis vaccine: is there value in the mucosal approach?
Diogo GR; Reljic R
Immunotherapy; 2014; 6(9):1001-13. PubMed ID: 25341121
[TBL] [Abstract][Full Text] [Related]
18. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
19. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection.
Nambiar JK; Ryan AA; Kong CU; Britton WJ; Triccas JA
Eur J Immunol; 2010 Jan; 40(1):153-61. PubMed ID: 19830735
[TBL] [Abstract][Full Text] [Related]
20. Rationalized design of a mucosal vaccine protects against
Ahmed M; Jiao H; Domingo-Gonzalez R; Das S; Griffiths KL; Rangel-Moreno J; Nagarajan UM; Khader SA
J Leukoc Biol; 2017 Jun; 101(6):1373-1381. PubMed ID: 28258153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
